if you dont load the truck now? dude, relax.
nothing happened. she bought stock below market.
you will have the opportunity to buy below 40 cents again. jsda is a penny stock now. it was a momentum trade and now the trade is over. until she announces actual good business news, this is a sh-t show.
now now. you have to give some credit to cue in believing in the company and her efforts. i would have been much happier to see a positive business announcement, than a financial announcement. but it is better than her not doing this. she could have just given herself more shares for free. they all do it. here at least she paid something. i hope they bring someone on board who understands what to do here. so far, no one has a clue. i hope it changes.
so admit it, they are not going anywhere out of business this year.
and of course they can dilute shares and raise money, they just did!
ceo buys stock from herself below market and announces her investment and the stock goes up. printing money.
other ceos might have bought at market and reduced the float. so cue printed money. ok. the stock has not gone up for business reasons in how long? more than a year?
sigh. normally that is a good sign. on the other hand, in this circumstance, i do not quite think it will help. clearly she is motivated to improve performance. sadly, i have not seen a single thing from her that makes any sense in 2014. she is like mortimer screaming turn those machines back on in trading places. she is already investing her time. carrie bailed coming to a different conclusion i imagine. i dont see where this helps much other than to set a price under the stock and bring in some money. i honestly would have much rather see someone come in who understood why the company is failing. i dont believe cue thinks the company is failing. i think she thinks everything is awesomesauce, the brand is kewl and omg people luv the brand cuz there are like a million facebook frendzzzz. the stock will likely hit the multi-year low when tax selling hits. around 21 cents. i think the company is overvalued at that price though. add in the share dilution of another 1.8 million shares.
i wonder what she thinks looking at reed performance by comparison. it must be baffling to have been bigger a couple years ago, to now be 20% of their cap. and reed is barely capable.
silliness. cue already said the loc is being paid down, not further drawn. so if she i lying ok take that position. otherwise the company can further dilute and further cut expenses to stay in business for years. they can trade at a penny and dilute. the key factor is paying the staff. they dont want to get other jobs it appears (other than carrie).
further muddying the water and in defense of the contrary argument:
Exclusive licensing of BRCA testing stifles research, including:
Research on PARP inhibitors, targeted therapy for BRCA-associated cancer: We believe that the BRCA gene patent has had a profound impact by delaying and slowing the development of targeted cancer therapies for people with BRCA mutations. PARP inhibitors are a class of drugs that were developed based on scientists' knowledge of how hereditary cancers develop in people with BRCA mutations. The drugs showed activity and early studies were promising in several types of hereditary cancers including breast, ovarian, and prostate. PARP inhibitor research has been ongoing since 2005, and today, seven years later, the drugs have yet to gain FDA approval. After meeting with the FDA, we were told that for targeted therapies that benefit a distinct population (such as people with a BRCA mutation) to receive FDA approval, they require that any companion laboratory test identifying a target population must be FDA approved as well. BRACAnalysis — Myriad's test for BRCA mutations is not FDA-approved. Myriad is a CLIA-approved laboratory; they were never required to receive FDA approval in order to market their test, and it doesn't appear that they have plans to seek FDA approval. Because Myriad holds the patent on the gene, no other lab can develop an FDA-approved test to identify BRCA mutation carriers.
one of the reasons sales are stalling for kombucha. smaller bottle than GT and higher price, with less promotion and marketing and product information.
good read. the ceo is from the early 2000s. she is trying the same strategies and thinks the market is the same.
like the pbj soda. know what is in it? i dont either. they dont publish ingredients on the website for many products. seems it too hard. tough to maintain a website with a staff of only 27 people and millions of dollars in losses.
you have to prove efficacy to the fda for diagnostic lab tests. holy #$%$. you think a lab can announce we can predict cancer with this blood test and then go a sell the test? and the fda goes hmmm, sure sounds good. taking those breasts off are ya? cool with us.
i have owned mygn stock for 15 years. performance has been fair. not good. fair. the stock is not near its highs from 14 years ago. it is not in the top 1000 best stocks to have owned for the last ten years i pretty sure. so i am not so impressed on that front. i think the company can do well going forward. i DO NOT think they have done a good job educating people, marketing or expanding internationally. maybe that will change. the angelina jolie press was fortunate and then wasted. utterly wasted. a crime that she was not brought on as a spokesperson for cancer screening. and they are blowing prolaris at this point as well. no one could research the test reasonably and understand it. not even a doctor.
"Myriad’s Prolaris is a genomic test applied to predict cancer-specific disease progression and mortality based on an analysis of 46 cell cycle progression genes. It is the only test available that shows prognostic value in both pre and post prostatectomy settings. Currently, it is approved by the FDA for use in low-risk men with a Gleason score of 6, as well as for post-prostatectomy patients who are categorized in the high-risk zone for prostate cancer recurrence." from mygn press release.
i assume you just make up your facts and manufacture outrage.
not much to say?
1. bargain. before you type in all caps, try and be correct. you are actually entirely incorrect. of course they need fda approval to market the tests. good lord.
2. newt. really: Prolaris has been proven to predict prostate cancer-specific disease progression in 4 published clinical trials. you made my point exactly. mygn says its effective, so move along.... not x more effective than another test. a cheaper test. a different protocol. the language is laughable. its like marketing fluff.
you still have not said anything AT ALL about the effectiveness of the test vs. current protocols. a 30% reduction in aggressive therapy relates to nothing at all. it is not how fda trial results are measured. wow. go through the prolaris website. find data.
that is the worst post i have ever seen from you.
no one really understands the benefits and data on prolaris, so trust your urologist. he has access to the secret data. #$%$? translation: you can't find information explaining prolaris either.
it would appear he does not have so much faith in AIRT's business. it is like a mutual fund here. less than $1 to the 52 week lows and he invests in interactive marketing and ads. clearly he does not see a way to spend the money on the main business so he tied it up in another utterly unrelated business with little liquidity but paying top dollar. a PE of 38! tempting....
of course not. why would they be? they can go for several more years, unless they get dropped by a major retailer. then the economy of scale is fully gone. personally, i think walmart will drop the line. they simply can not be selling much soda, because no one is selling much of this product.
i have problem with them doing flavors like this, provided it is done at a profit and with some degree of pride. unfortunately the soda itself is a hot mess and completely contrary to trend. a parent might allow a child to buy one as a treat. not a way to build a business. and as i have been saying, they make soda for children. here finally, jennifer clueless shows that is exactly what they are doing. building a brand targeted at kids with chemicals for ingredients. back to school with chemical colored fizzy water. and they think this is "cool"